Svas Biosana S.p.A.'s latest marketcap:
As of 07/05/2025, Svas Biosana S.p.A.'s market capitalization has reached $50.3 M. According to our data, Svas Biosana S.p.A. is the 29734th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 50.3 M |
| Revenue (ttm) | 143.99 M |
| Net Income (ttm) | 6.92 M |
| Shares Out | 5.31 M |
| EPS (ttm) | 1.3 |
| Forward PE | 6.18 |
| Ex-Dividend Date | 06/09/2025 |
| Earnings Date | 06/27/2025 |
Svas Biosana S.p.A.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €50.3 M | 11.46% | 29734 |
| 12/30/2024 | €38.33 M | -11.25% | 29608 |
| 12/29/2023 | €43.19 M | -20.87% | 28083 |
| 12/30/2022 | €54.58 M | -37.13% | 25833 |
| 12/30/2021 | €86.8 M | 23187 |
Company Profile
About SVAS Biosana S.p.A.
SVAS Biosana S.p.A. is a global leader in the production and marketing of high-quality medical devices. Founded in 1972 and headquartered in Somma Vesuviana, Italy, the company specializes in a diverse range of healthcare solutions.
Product Offerings
SVAS Biosana provides innovative medical products across multiple applications, including:
- Incontinence & Personal Care: Aids and products designed for incontinence management and personal hygiene.
- Wound Care: Traditional and advanced dressings for effective wound treatment.
- Surgical & Critical Care: Operating packs, infusion/aspiration devices, and lubricating gels for haemodynamic, heart surgery, anaesthesia, and intensive care.
- Specialist Medical Devices: Solutions for oncology, chronic illnesses, radiology, orthopaedics, cardiology, and diagnostic imaging.
With decades of expertise, SVAS Biosana S.p.A. remains committed to delivering reliable and advanced medical technologies to improve patient care worldwide.
Frequently Asked Questions
-
What is Svas Biosana S.p.A.'s (BIT-SVS) current market cap?As of 07/05/2025, Svas Biosana S.p.A. (including the parent company, if applicable) has an estimated market capitalization of $50.3 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Svas Biosana S.p.A. (BIT-SVS) rank globally by market cap?Svas Biosana S.p.A. global market capitalization ranking is approximately 29734 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.